Insider Trading & Ownership - Column Group Opportunity III LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Column Group Opportunity III LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-12
Purchase
2024-02-14
4:15 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
2,222,222$4.5$9,999,99922,999,565
(Indirect)
View
2023-11-15
Purchase
2023-11-17
4:30 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-03-10
Purchase
2023-03-14
4:12 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
6,779$2.5956$17,59620,777,343
(Indirect)
View
2023-02-08
Purchase
2023-02-10
4:32 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
1,500,000$2.6$3,900,00020,770,564
(Indirect)
View
2023-01-30
Purchase
2023-02-01
4:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:25 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
69,739$2.4979$174,20119,270,564
(Indirect)
View
2023-01-19
Purchase
2023-01-23
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-17
Purchase
2023-01-19
4:18 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
185,151$2.5105$464,82719,200,825
(Indirect)
View
2023-01-12
Purchase
2023-01-17
4:34 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:37 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:12 pm
Tenaya Therapeutics Inc.TNYACOLUMN GROUP III GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group Opportunity III LP
Column Group Opportunity III GP LP
TCG Opportunity III GP LLC
10% Owner
9,615,384$2.6$24,999,99819,015,674
(Indirect)
View
2022-11-03
Purchase
2022-11-07
4:20 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:55 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-05
Other
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
1,000$02,000
(Indirect)
View
2024-04-05
Disposition
2024-04-08
8:04 pm
N/A
N/A
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
20,344,505$02,000
(Indirect)
View